View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Air Liquide poursuit sa trajectoire en réalisant à nouveau un trimestr...

PARIS--(BUSINESS WIRE)-- Regulatory News: Air Liquide (Paris:AI): Chiffres clés (en millions d'euros) T1 2024 2024/2023 publié 2024/2023 comparable(a) Chiffre d’affaires Groupe 6 650 - 7,3 % + 2,1 % dont Gaz & Services 6 358 - 7,8 % + 2,0 % dont Ingénierie & Construction 92 + 5,2 % + 6,5 % dont Marchés Globaux & Technologies 200 + 3,7 % + 4,7 % (a) Variation hors effets de change, d’énergie (gaz naturel et électricité) et de périmètre significatif, voir ré...

ABGSC Oil & Oil Services Research ... (+2)
  • ABGSC Oil & Oil Services Research
  • John Olaisen
 PRESS RELEASE

EQS-News: Blue Cap AG publishes 2023 annual report and proposes divide...

EQS-News: Blue Cap AG / Key word(s): Annual Report/Dividend Blue Cap AG publishes 2023 annual report and proposes dividend of EUR 0.65 per share 24.04.2024 / 07:09 CET/CEST The issuer is solely responsible for the content of this announcement. Group revenue in financial year 2023 at EUR 273.3 million, adjusted EBITDA margin of 8.5% Net asset value (NAV) amounts to EUR 112.3 million as at 31 December 2023 Dividend proposal of EUR 0.65 per share follows proven dividend policy For 2024, the Executive Board forecasts revenue of EUR 270-290 million and an adjusted EBITDA ma...

 PRESS RELEASE

EQS-News: Blue Cap AG veröffentlicht Geschäftsbericht 2023 und schlägt...

EQS-News: Blue Cap AG / Schlagwort(e): Jahresbericht/Dividende Blue Cap AG veröffentlicht Geschäftsbericht 2023 und schlägt Dividende von 0,65 Euro je Aktie vor 24.04.2024 / 07:09 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Konzernumsatz im Geschäftsjahr 2023 bei 273,3 Mio. Euro, adjusted EBITDA-Marge von 8,5 % Net Asset Value (NAV) per 31.12.2023 beläuft sich auf 112,3 Mio. Euro Dividendenvorschlag von 0,65 Euro je Aktie folgt bewährter Dividendenpolitik Für 2024 prognostiziert der Vorstand einen Umsatz von 270-290 Mio. Euro ...

 PRESS RELEASE

EQS-News: Evotec SE stellt Ergebnisse für das Geschäftsjahr 2023 vor u...

EQS-News: Evotec SE / Schlagwort(e): Jahresergebnis Evotec SE stellt Ergebnisse für das Geschäftsjahr 2023 vor und richtet Priorität auf profitables Wachstum aus 24.04.2024 / 07:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. FINANZERGEBNIS 2023 ERREICHT IN ALLEN PUNKTEN DIE AKTUALISIERTE PROGNOSE NEUAUSRICHTUNG DER PRIORITÄT AUF PROFITABLES WACHSTUM: ANPASSUNGEN BEI GRÖẞE UND STANDORTEN, UM JÄHRLICHEN EBITDA-BEITRAG VON MEHR ALS 40 MIO. € ZU ERREICHEN EVOTECS BERICHTSSTRUKTUR VERÄNDERT SICH MIT DEM ERSTEN QUARTAL 2024 ZU DEN SEG...

 PRESS RELEASE

EQS-News: SURTECO GROUP SE: Good start to the business year 2024 after...

EQS-News: SURTECO GROUP SE / Key word(s): Annual Report SURTECO GROUP SE: Good start to the business year 2024 after a difficult year in 2023 24.04.2024 / 07:05 CET/CEST The issuer is solely responsible for the content of this announcement. SURTECO GROUP SE: Good start to the business year 2024 after a difficult year in 2023  Earnings per share in 2023 amount to € -0.79 after € 1.63 in the previous year Sales for 2024 are projected to be in the range € 860 to 910 million. Adjusted EBITDA is expected between € 85 and 105 million. Good start to the business year 2024 wit...

 PRESS RELEASE

EQS-News: SURTECO GROUP SE: Guter Start in das Geschäftsjahr 2024 nach...

EQS-News: SURTECO GROUP SE / Schlagwort(e): Jahresbericht SURTECO GROUP SE: Guter Start in das Geschäftsjahr 2024 nach schwierigem Jahr 2023 24.04.2024 / 07:05 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. SURTECO GROUP SE: Guter Start in das Geschäftsjahr 2024 nach schwierigem Jahr 2023    Gewinn je Aktie liegt in 2023 bei -0,79 € nach 1,63 € im Vorjahr Umsatz 2024 soll bei 860 bis 910 Mio. € liegen. EBITDA adjusted wird zwischen 85 und 105 Mio. € erwartet. Guter Start in das Geschäftsjahr 2024 mit einem Plus von 44 % im EBITD...

 PRESS RELEASE

EQS-News: Evotec presents fiscal year 2023 results and announces prior...

EQS-News: Evotec SE / Key word(s): Annual Results Evotec presents fiscal year 2023 results and announces priority reset to focus on profitable growth 24.04.2024 / 07:00 CET/CEST The issuer is solely responsible for the content of this announcement. FINANCIAL RESULTS FOR 2023 FULLY MET UPDATED GUIDANCE PRIORITY RESET TO PROFITABLE GROWTH: SIZE & FOOTPRINT ADJUSTMENTS TO DRIVE EXPECTED ANNUALISED EBITDA IMPROVEMENT GREATER THAN € 40 M EVOTEC’S REPORTING STRUCTURE WILL CHANGE TO BUSINESS SEGMENTS “SHARED R&D” AND “JUST – EVOTEC BIOLOGICS” STARTING Q1 2024 Hamburg, Germany,...

Growthpoint Finance Pty Limited: Update to credit analysis

Our credit view of this issuer reflects its transparent business model, with majority of the income derived from rent under lease contracts, offset by its acquisitive nature.

 PRESS RELEASE

Kalray Joins Arm Total Design, Extending Collaboration With Arm on Acc...

GRENOBLE, France--(BUSINESS WIRE)-- Kalray (Euronext Growth Paris: ALKAL), a leading provider of hardware and software solutions to accelerate data intensive workflows from Cloud to Edge, announced that it has extended its collaboration with Arm by joining Arm Total Design. Through a deeper connection to industry leaders who are leveraging Arm® Neoverse™ Compute Subsystems (CSS), Kalray can help more companies integrate its unique AI and data acceleration technology and help Arm ecosystem partners commercialize AI-based solutions in a fraction of the time and cost usually needed. Arm Total D...

 PRESS RELEASE

KALRAY DEVIENT MEMBRE DU PROGRAMME « ARM TOTAL DESIGN », RENFORÇANT SA...

GRENOBLE, France--(BUSINESS WIRE)-- Kalray (Euronext Growth Paris : ALKAL), leader dans les technologies matérielles et logicielles dédiées à la gestion et au traitement intensif des données du Cloud au Edge, annonce devenir membre du programme Arm Total Design de Arm. En travaillant plus étroitement avec les leaders de l'industrie qui exploitent les solutions CSS d’Arm (Compute Sub-System Solution), Kalray va permettre à davantage d'entreprises d’intégrer plus facilement sa technologie unique d'accélération de l'IA et du traitement des données. En outre, Kalray aidera les partenaires de l'éco...

ABGSC Metals & Mining Research ... (+2)
  • ABGSC Metals & Mining Research
  • Adrian Gilani

The low point is behind us, time to BUY

Q1 was the low point, outlook significantly better. Higher prices and weaker SEK drive positive revisions. Share up to BUY (Hold), new TP SEK 390 (310).

 PRESS RELEASE

Elliptic Labs Shipping Its AI Software Platform on Lenovo’s Newest Thi...

OSLO, Norway--(BUSINESS WIRE)-- (OSE:), a global AI software company and the world leader in AI Virtual Smart Sensors™, is now shipping its 100% software-only AI Virtual Human Presence Sensor on four select models of latest generation ThinkPad P Series workstation laptops — ThinkPad P1 Gen 7, P16v i Gen 2, P16s i Gen 3, and P14s i Gen 5. Elliptic Labs’ partner sits at these laptops’ core with its latest generation . Elliptic Labs announced the contract preceding this launch . Elliptic Labs’ AI Virtual Smart Sensor Platform™ leverages the company’s ultrasound, AI, and sensor fusion experti...

 PRESS RELEASE

Galderma Delivers a Strong Start to the Year With Record Net Sales of ...

ZUG, Switzerland--(BUSINESS WIRE)-- Galderma Group AG (SWX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first quarter of 2024. Record net sales of 1.071 billion USD in the first quarter of 2024, surpassing for the first time the 1 billion USD mark for the first three months in a year Net sales growth for the first quarter of 2024 was 12.4% year-on-year on a constant currency basis1, primarily driven by volume Broad-based growth across all product categories, with constant currency year-on-year growth of 19.3% for Injectable Aesthetics...

 PRESS RELEASE

Pharming to be honored as Industry Innovator at National Organization...

Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards Recognition given for achievement in commercializing Joenja® (leniolisib), a first-in-class medication brought to market 10 years after disease state, APDS, was first characterized Leiden, the Netherlands, April 24, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is pleased to announce its recognition as an Industry Innovator by the National Organization for Rare Disorders (NORD®) at the Rare Impact Awards on June 8, 2024...

 PRESS RELEASE

Vopak reports strong Q1 2024 results and increases FY 2024 outlook

Vopak reports strong Q1 2024 results and increases FY 2024 outlook The Netherlands, 24 April 2024 Vopak reports strong Q1 2024 results and increases FY 2024 outlook Key highlights Q1 2024 Improve Increased net profit -including exceptional items1- in Q1 2024 to EUR 106 million, an improvement of 3% year-on-year, driven by favorable storage demand across different geographies and marketsIncreased proportional EBITDA -excluding exceptional items1- in Q1 2024 to EUR 298 million, an improvement of 9% year-on-year when adjusted for divestment impacts of EUR 21 millionFurther strength...

 PRESS RELEASE

Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results an...

Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates In-depth analysis of VIVIAD Phase 2b results is ongoing, including pre-specified and exploratory endpoints; findings to date are consistent with previously announced topline data observing no statistically significant or clinically meaningful effect of varoglutamstat on cognition and function in early AD up to 600mg twice a day (BID) doseStatistically sig...

 PRESS RELEASE

Borregaard ASA: EBITDA1 of NOK 442 million in the 1st quarter

Borregaard ASA: EBITDA1 of NOK 442 million in the 1st quarter Borregaard’s operating revenues reached NOK 1,975 million (NOK 1,850 million)2 in the 1st quarter of 2024. EBITDA1 increased to NOK 442 million (NOK 435 million). The result in BioSolutions increased while results in BioMaterials and Fine Chemicals were lower compared with the 1st quarter of 2023. The result in BioSolutions increased due to higher sales volume and reduced energy costs. In BioMaterials, higher sales volume was more than offset by lower sales prices and higher wood costs. Fine Chemicals had a lower result due to l...

 PRESS RELEASE

Reminder: Unifiedpost Group Strategy Update Presentation on 30 April 2...

Reminder: Unifiedpost Group Strategy Update Presentation on 30 April 2024 La Hulpe, Belgium – 24 April 2024, 7:00 a.m. CET – Unifiedpost Group SA (Euronext Brussels: UPG) (“Unifiedpost”), a leader in cloud-based business process solutions, will present an overview of its mid-term strategy on Tuesday, 30 April 2024.The event will take place from 2:00pm to 4:00pm CET on Tuesday, 30 April 2024. The presenting team will be Hans Leybaert, CEO, Koen De Brabander, CFO, and some of the group’s business leaders. The agenda for the day is as follows: Introductions Key objectives Business updat...

 PRESS RELEASE

Wereldhave Trading update Q1 2024

Wereldhave Trading update Q1 2024 Full Service Center footfall continues to power ahead: 10% above Q1 2023Retail sales +5%, well above inflationPolarizing leasing market in the Benelux with several expanding formulas but also some bankruptciesLeasing spreads in the Netherlands moving into positive territoryRent collection >97% underpinning tenant qualityLTV improved to 41.5% due to positive Belgian revaluations (ERV driven) and targeted CAPEXUpdate on short-term strategic focus: rotating capital out of the Netherlands to further reduce LTVFull Service Center Sterrenburg awarded with the 202...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch